DE60213968D1 - Blutgerinnungsfaktor xiii zur behandlung von plättchenfunktionsstörungen - Google Patents

Blutgerinnungsfaktor xiii zur behandlung von plättchenfunktionsstörungen

Info

Publication number
DE60213968D1
DE60213968D1 DE60213968T DE60213968T DE60213968D1 DE 60213968 D1 DE60213968 D1 DE 60213968D1 DE 60213968 T DE60213968 T DE 60213968T DE 60213968 T DE60213968 T DE 60213968T DE 60213968 D1 DE60213968 D1 DE 60213968D1
Authority
DE
Germany
Prior art keywords
factor xiii
blood
treatment
plate features
creation factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60213968T
Other languages
English (en)
Other versions
DE60213968T2 (de
Inventor
D Bishop
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of DE60213968D1 publication Critical patent/DE60213968D1/de
Application granted granted Critical
Publication of DE60213968T2 publication Critical patent/DE60213968T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60213968T 2001-02-21 2002-02-07 Blutgerinnungsfaktor xiii zur behandlung von plättchenfunktionsstörungen Expired - Lifetime DE60213968T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27047001P 2001-02-21 2001-02-21
US270470P 2001-02-21
PCT/US2002/003770 WO2002067981A1 (en) 2001-02-21 2002-02-07 Blood coagulation factor xiii for treating platelet disorders

Publications (2)

Publication Number Publication Date
DE60213968D1 true DE60213968D1 (de) 2006-09-28
DE60213968T2 DE60213968T2 (de) 2007-08-30

Family

ID=23031445

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60213968T Expired - Lifetime DE60213968T2 (de) 2001-02-21 2002-02-07 Blutgerinnungsfaktor xiii zur behandlung von plättchenfunktionsstörungen

Country Status (7)

Country Link
EP (1) EP1387691B1 (de)
JP (1) JP2004537505A (de)
AT (1) ATE336261T1 (de)
CA (1) CA2438763A1 (de)
DE (1) DE60213968T2 (de)
ES (1) ES2268017T3 (de)
WO (1) WO2002067981A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080176789A1 (en) 2004-08-27 2008-07-24 Novc Nordisk Healthcare A/G Purification of Factor Xlll Polypeptides From Biological Materials

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE66374T1 (de) * 1985-11-26 1991-09-15 Novo Nordisk As Zubereitungen und verfahren zur behandlung von blutungsstoerungen.
US5612456A (en) * 1988-11-14 1997-03-18 Zymogenetics, Inc. Factor XIII compositions
US5622988A (en) * 1990-06-15 1997-04-22 Novo Nordisk A/S Use of a low molecular weight metabolite from fungus for reducing prolonged coagulation time
JPH07502734A (ja) * 1991-12-31 1995-03-23 ザイモジェネティクス，インコーポレイティド 血液損失を減少する方法および組成物
ATE184199T1 (de) * 1992-11-12 1999-09-15 Zymogenetics Inc Verwendung von lokal appliziertem faktor xiii zur verhinderung von blutungen

Also Published As

Publication number Publication date
JP2004537505A (ja) 2004-12-16
EP1387691B1 (de) 2006-08-16
ATE336261T1 (de) 2006-09-15
EP1387691A1 (de) 2004-02-11
ES2268017T3 (es) 2007-03-16
CA2438763A1 (en) 2002-09-06
WO2002067981A1 (en) 2002-09-06
DE60213968T2 (de) 2007-08-30

Similar Documents

Publication Publication Date Title
ATE468137T1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
ATE380548T1 (de) Verwendung von p53 inhibitoren zur behandlung von nebenerscheinungen bei der krebstherapie
DE69921156D1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
ATE348808T1 (de) Azacyclische verbindungen zur verwendung in der behandlung von mit serotonin verwandten krankheiten
DE60113548D1 (de) Cyanomethyl-substituierte thiazolium- und imidazolium-verbindungen und behandlung von erkrankungen im zusammenhang mit proteinalterung
CY1109650T1 (el) Χρηση νευρικων νηματικων πρωτεϊνων για την αντιμετωπιση νεοπλασιων
DE60101265D1 (de) Behandlung von augenschmerzen
CY1107640T1 (el) Μεθοδος για πιστοποιηση παραγοντων για τη θεραπεια διαβητη
DE69929464D1 (de) Zyklische polyamine zur behandlung der thrombozytopenie
ATE293972T1 (de) Behandlung von chronischen schmerzen
DE60213968D1 (de) Blutgerinnungsfaktor xiii zur behandlung von plättchenfunktionsstörungen
ATE382354T1 (de) Präoperative behandlung von postoperativen schmerzen
ATE354361T1 (de) Neue verwendung von prodigiosin zur behandlung von diabetes mellitus
ATE264101T1 (de) Verwendung von thioamidoxazolidinonen zur behandlung von knochenresorption und osteoporose
ATE337004T1 (de) Verwendung von mangafodipir zur behandlung der hepatozellularen insuffizienz
DE60128130D1 (de) Verwendung des blutgerinnungsfaktors xiii für die behandlung der hämophilie a
ATE174507T1 (de) Verwendung eines benzimidazolwurmmittels zur behandlung von mikrosporeninfektionen
ATE367824T1 (de) Faktor xiii in kombination mit faktor ix zur behandlung von hämophilie b
ATE423780T1 (de) Makrozyclen zur behandlung von krebserkrankungen
DE60128084D1 (de) Verwendung von inaktives cln2 proenzym zur behandlung von lincl
ATE288263T1 (de) Verwendung von n-oleoylethanolamin zur behandlung der schuppenflechte (psoriasis)
ATE214923T1 (de) Verwendung von (r)-verapamil als medizin zur behandlung von angina
DE60143390D1 (de) Methode zur behandlung von herzinsuffizienz
ATE382367T1 (de) Behandlung des typ 1 diabetes vor und nach expression von prädispositionsmarkern
ATE291434T1 (de) Verwendung von angiotensin zur behandlung von krebsmetastasierung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition